COMPOUND PROFILE / PEPTIDES & ANALOGUES
HNG / S14G-Humanin.
Research draftHNG, also called S14G-Humanin, is a modified Humanin analogue.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
HNG, also called S14G-Humanin, is a modified Humanin analogue.
Mechanism
The substitution alters experimental activity in cell-survival pathways.
Human research
Native Humanin biomarker observations cannot establish HNG treatment benefit.
Preclinical & other research
Cell and animal studies investigated amyloid toxicity and platelet responses.
Safety & unknowns
Therapeutic human exposure and long-term safety are not established.
Regulatory status
Preclinical candidate, distinct from native Humanin.
Reported use & evidence
The supplied HNG / S14G-Humanin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.